| Corrigendum: miR-182 integrates apoptosis, growth, and differentiation programs in glioblastoma FM Kouri, LA Hurley, WL Daniel, ES Day, Y Hua, L Hao, CY Peng, ... Genes & development 38 (7-8), 355, 2024 | | 2024 |
| Cavrotolimod, a Nanoparticle Toll-like Receptor 9 Agonist, Inhibits Tumor Growth and Alters Immune Cell Composition in Mouse Models of Skin Cancer S Mix, M Schroff, WL Daniel ACS Applied Nano Materials 6 (4), 2682-2696, 2023 | 1 | 2023 |
| A first-in-human phase 1 study of cavrotolimod, a TLR9 agonist spherical nucleic acid, in healthy participants: Evidence of immune activation WL Daniel, U Lorch, S Mix, AS Bexon Frontiers in Immunology 13, 1073777, 2022 | 8 | 2022 |
| Combined spherical nucleic acid and checkpoint inhibitor for antitumor therapy P Patel, W Daniel, A Bexon, M Schroff US Patent App. 17/430,277, 2022 | 2 | 2022 |
| Spherical Nucleic Acid Nanoparticle Conjugates as an RNAi-Based Therapy for Glioblastoma SA From Jensen, ES Day, CH Ko, LA Hurley, JP Luciano, FM Kouri, ... Spherical Nucleic Acids: Volume 4, 1625, 2021 | | 2021 |
| 423 Safety and preliminary efficacy of intratumoral cavrotolimod (AST-008), a spherical nucleic acid TLR9 agonist, in combination with pembrolizumab in patients with advanced … S O’Day, C Perez, T Wise-Draper, G Hanna, S Bhatia, C Kelly, T Medina, ... Journal for ImmunoTherapy of Cancer 8 (Suppl 3), 2020 | 17 | 2020 |
| Anti-tnf compounds CC Mader, TL Halo, S Gryaznov, R Kang, W Daniel US Patent App. 16/930,977, 2020 | 5 | 2020 |
| Nucleic acid nanostructures with core motifs W Daniel, MIX Scott US Patent App. 16/883,756, 2020 | 5 | 2020 |
| Biodistribution of Spherical Nucleic Acids in the Nonhuman Primate Central Nervous System GT Corbett, LR Moore, S Mix, A Schook, SR Nallagatla, WL Daniel, ... ANNALS OF NEUROLOGY 88, S219-S219, 2020 | | 2020 |
| Anti-TNF compounds CC Mader, TL Halo, S Gryaznov, R Kang, W Daniel US Patent 10,760,080, 2020 | 8 | 2020 |
| Gold nanoparticles for biology and medicine DA Giljohann, DS Seferos, WL Daniel, MD Massich, PC Patel, CA Mirkin Spherical Nucleic Acids, 55-90, 2020 | 2835 | 2020 |
| Polyvalent Oligonucleotide Gold Nanoparticle Conjugates as Delivery Vehicles for Platinum (IV) Warheads S Dhar, WL Daniel, DA Giljohann, CA Mirkin, SJ Lippard Spherical Nucleic Acids, 1585-1591, 2020 | 1 | 2020 |
| Spherical nucleic acid nanoparticle conjugates as an RNAi-based therapy for glioblastoma SA Jensen, ES Day, CH Ko, LA Hurley, JP Luciano, FM Kouri, TJ Merkel, ... Spherical nucleic acids, 1625-1648, 2020 | 1 | 2020 |
| Abstract LB-140: Phase 1b/2 study of an intratumoral TLR9 agonist spherical nucleic acid (AST-008) and pembrolizumab: Evidence of immune activation MM Milhem, CA Perez, GJ Hanna, TM Wise-Draper, S Bhatia, AS Bexon, ... Cancer Research 80 (16_Supplement), LB-140-LB-140, 2020 | 2 | 2020 |
| Nucleic acid nanostructures with core motifs W Daniel, MIX Scott US Patent 10,704,043, 2020 | 9 | 2020 |
| AST-008: A novel approach to TLR9 agonism with PD-1 blockade for anti-PD-1 refractory Merkel cell carcinoma (MCC) and cutaneous squamous cell carcinoma (CSCC). MM Milhem, CA Perez, GJ Hanna, TM Wise-Draper, S Bhatia, AS Bexon, ... Journal of Clinical Oncology 38 (15_suppl), TPS3164-TPS3164, 2020 | 6 | 2020 |
| Spherical Nucleic Acids (SNAs) for the Treatment of Neurologic Diseases (1832) G Corbett, L Moore, S Mix, A Schook, SR Nallagatla, W Daniel, L Kelly, ... Neurology 94 (15_supplement), 1832, 2020 | | 2020 |
| Targeting the IL-17 receptor using liposomal spherical nucleic acids as topical therapy for psoriasis H Liu, RS Kang, K Bagnowski, JM Yu, S Radecki, WL Daniel, ... Journal of Investigative Dermatology 140 (2), 435-444. e4, 2020 | 40 | 2020 |
| Abstract CT044: AST-008, a TLR9 agonist spherical nucleic acid, activated NK cells, T cells, and cytokines in healthy subjects in a phase I clinical trial WL Daniel, U Lorch, S Coates, AS Bexon, S Mix Cancer Research 79 (13_Supplement), CT044-CT044, 2019 | 5 | 2019 |
| AST-008, a TLR9 agonist spherical nucleic acid, activated NK cells, T cells, and cytokines in healthy subjects in a phase I clinical trial WL Daniel, U Lorch, S Coates, AS Bexon, S Mix CANCER RESEARCH 79 (13), 2019 | 1 | 2019 |
